Filing Flows › Comparisons › ARQ vs PURE
Arq vs Pure Bioscience: ARQ and PURE compared
Arq is the larger company: $38.2M of revenue in its latest quarter (Q3 2026) against $659K for Pure Bioscience (Q4 FY26). Arq is growing faster (+9% against -14% a year earlier). Arq is more profitable, with an operating margin of 8.2% against -76.3%.
Where the money goes: ARQ and PURE
Arq (ARQ) · Q3 2026
Arq, Q3 2026: revenue $38.2M (+9% year over year), operating margin 8.2%, net earnings $2.5M, operating cash flow $10.3M. The chart follows the revenue to costs, profit and cash.
Pure Bioscience (PURE) · Q4 FY26
Pure Bioscience, Q4 FY26: revenue $659K (-14% year over year), operating margin -76.3%, net loss $610K, operating cash flow −$414K. The chart follows the revenue to costs, profit and cash.
| Arq (ARQ) | Pure Bioscience (PURE) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q4 FY26 |
| Revenue | $38.2M | $659K |
| Revenue growth, Y/Y | +9% | -14% |
| Operating margin | 8.2% | -76.3% |
| Net earnings | $2.5M | −$610K |
| Net margin | 6.5% | -92.6% |
| Operating cash flow | $10.3M | −$414K |
| Free cash flow | $9.6M | — |
Where the revenue comes from
Pure Bioscience
- Product: $659K (100%)
- Royalty: $1K (0%)
Questions
Which is bigger, Arq or Pure Bioscience?
Arq is the larger company: $38.2M of revenue in its latest quarter (Q3 2026) against $659K for Pure Bioscience (Q4 FY26).
Is Arq or Pure Bioscience growing faster?
Arq is growing faster (+9% against -14% a year earlier).
Which is more profitable, Arq or Pure Bioscience?
Arq is more profitable, with an operating margin of 8.2% against -76.3%.
More: Arq earnings · how Arq makes money · Pure Bioscience earnings · how Pure Bioscience makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-K filed Oct 29, 2026). Fiscal quarters can end on different dates. Not investment advice.